The Brazilian state of São Paulo is expected to receive next month 5 million doses of the CoronaVac vaccine, which is being developed by Brazil’s Butantan Institute, in partnership with the Chinese pharmaceutical company Sinovac Biotech. The announcement was made by São Paulo’s governor, João Doria, in an interview with Veja magazine, and posted on his Facebook page on Sunday.
According to Doria, there should be 46 million doses available by December. As he explained in the social media post, this would be possible due to the transfer of technology from the pharmaceutical company to the institute, which will start to produce the substance.
Last Monday, the state administration informed that the institute will start, in November, works to expand its physical structure, in order to accelerate the production of vaccines. According to Agência Brasil, the state government expects the reform to be completed this month.
CoronaVac is already in phase 3 of human testing. The tests, under the responsibility of the Butantan Institute, began to be carried out in Brazil in July and will be applied to 9,000 volunteers. The testing was organized from 12 research centers, located in Brazilian states of São Paulo, Brasília, Rio de Janeiro, Minas Gerais, Rio Grande do Sul and Paraná.